Comparing the Effects of Thorotrast and Zirconotrast in Mice
Author Information
Author(s): J. P. M. Bensted, J. 0. Crookall
Primary Institution: Institute of Cancer Research
Hypothesis
The carcinogenic effect of Thorotrast may be related to its physical properties rather than its radioactivity.
Conclusion
The study found no significant difference in liver tumor incidence between mice injected with Thorotrast and those injected with the non-radioactive Zirconotrast.
Supporting Evidence
- Both Thorotrast and Zirconotrast were administered intravenously to groups of mice.
- Histological studies were conducted on various organs after the mice were killed.
- Five liver tumors were observed in the Thorotrast group, and five in the Zirconotrast group.
Takeaway
Researchers wanted to see if a non-radioactive substance caused the same problems as a radioactive one in mice, and they found that both caused similar issues.
Methodology
Mice were injected with either Thorotrast or Zirconotrast and observed for tissue damage and tumor incidence over 18 months.
Limitations
The small sample size may limit the generalizability of the findings.
Participant Demographics
Fifty-two male Schofield mice, aged 30-35 grams.
Want to read the original?
Access the complete publication on the publisher's website